Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Remedent stock

REMI
US75954T1043
A0ERVL

Price

0.05 USD
Today +/-
+0 USD
Today %
+0 %

Remedent stock price

USD
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Remedent stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Remedent stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Remedent stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Remedent's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Remedent Stock Price History

DateRemedent Price
11/22/20240.05 USD

Remedent Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Remedent, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Remedent from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Remedent’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Remedent. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Remedent’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Remedent’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Remedent’s growth potential.

Remedent Revenue, EBIT and net profit per share

DateRemedent RevenueRemedent EBITRemedent Net Income
2022402,000 USD66,000 USD132,000 USD
2021289,000 USD0 USD0 USD
20201.06 M USD-479,610 USD-858,220 USD
20191.6 M USD-717,350 USD2.13 M USD
20182.7 M USD-300,760 USD-54,590 USD
20172.36 M USD-1.07 M USD844,370 USD
20162.77 M USD7,220 USD160,800 USD
20153.62 M USD105,420 USD105,160 USD
20142.59 M USD-740,000 USD520,000 USD
20132.94 M USD-1.81 M USD-980,000 USD
20129.69 M USD-500,000 USD490,000 USD
201112.58 M USD230,000 USD-1.55 M USD
20108.25 M USD-2.95 M USD-2.35 M USD
200914.64 M USD-950,000 USD-2.95 M USD
20087.48 M USD-3.07 M USD-3.12 M USD
20076.68 M USD-1.4 M USD-1.5 M USD
20067.39 M USD-3.12 M USD-3.89 M USD
20057.07 M USD890,000 USD-100,000 USD
20045.24 M USD720,000 USD20,000 USD
20031.97 M USD-630,000 USD-1.01 M USD

Remedent Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M USD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M USD)NET INCOME (M USD)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20032004200520062007200820092010201120122013201420152016201720182019202020212022
1577671481292232221100
-400.0040.00--14.2916.67100.00-42.8650.00-25.00-77.78-50.00-33.33---50.00---
100.0040.0057.1442.8650.0042.8657.1437.5066.6777.7850.0050.0066.6750.0050.0050.00100.00100.00--
02433383871121111000
-100-3-1-3-2-2-100000002000
-----66.67200.00-33.33--50.00-----------
1.822.052.0511.1212.9717.8219.56202020.02202020202020202000
--------------------
Details

Keystats

Revenue and Growth

The Remedent Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Remedent is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M USD)RECEIVABLES (M USD)OTHER REC. (M USD)INVENTORIES (M USD)OTHER CURRENT LIAB. (M USD)CURRENT ASSETS (M USD)TANGIBLE ASSETS (M USD)LONG-T. INVEST. (M USD)LONG-T. REC. (k USD)INTANGIBLE ASSETS (k USD)GOODWILL (k USD)OTHER NON-CURRENT ASSETS (M USD)NON-CURRENT ASSETS (M USD)TOTAL ASSETS (M USD)LIABILITIESCOMMON STOCK (M USD)ADDITIONAL PAID-IN CAPITAL (M USD)RETAINED EARNINGS (k USD)OTHER EQUITY (k USD)UNREAL. GAINS/LOSSES (M USD)EQUITY (M USD)LIABILITIES (M USD)PROVISIONS (M USD)OTHER SHORT-TERM LIAB. (k USD)SHORT-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)SHORT-TERM REC. (M USD)LONG-T. LIAB. (M USD)DEFERRED TAXES (M USD)OTHER LIAB. (M USD)LONG-T. LIABILITIES (M USD)DEBT (M USD)TOTAL CAPITAL (M USD)
2003200420052006200720082009201020112012201320142015201620172018201920202022
                                     
00.170.040.330.131.731.810.611.660.20.060.780.40.090.150.090.070.110
0.321.51.642.371.721.93.210.812.760.840.950.790.850.980.941.160.230.332.31
000000000001.151.151.1500000.22
0.120.430.561.471.131.361.942.162.161.080.990.60.410.410.110.120.110.090.09
0.30.310.320.410.670.971.310.920.761.150.570.130.10.230.080.30.240.150
0.742.412.564.583.655.968.274.57.343.272.573.452.912.861.281.670.660.682.62
0.040.040.090.320.590.691.031.741.40.640.70.490.440.410.270.140.130.070.02
000000.680.750.7503.063.232.222.22.433.173.627.116.761.97
0000000000000000059219
0060170140120160250170030207.10000034
00000007007000000000000
0000000000000000000
0.040.040.150.490.731.491.943.442.273.73.962.732.642.843.443.777.246.892.24
0.782.452.715.074.387.4510.217.949.616.976.536.185.545.74.735.447.97.574.86
                                     
0.040.0400.010.010.020.020.020.020.020.020.020.020.020.020.020.020.022.21
4.825.25.4311.6211.917.9324.1124.8424.952525252525252525250
-5,680-5,660-5,760-9,650-11,150-14,260-17,220-19,570-21,110-20,620-21,600-21,080-20,974.9-20,814.1-19,969.73-20,024.32-17,717.17-18,575.39996
-50-4060-30-3030-640-650-830-1,680-1,120-790-1,185.1-1,195.18-1,114.23-936.55-1,082.99-1,070.240
0000000000000000000
-0.87-0.46-0.271.950.733.726.274.643.032.722.33.152.863.013.944.066.225.383.21
1.010.80.951.691.4921.42.21.841.070.970.740.850.791.041.571.922.291.17
0.270.350.370.60.410.571.290.370.880.540.740.450.330.350.440.420.450.490.19
0020010002303401208506015012087.7573.4372.24133.6563.85100.5768
0.361.180.290.641.540.780.660.672.561.080.840.270000000
0000.010.040.060.080.220.180.861.212.262.172.2200000
1.642.331.813.043.483.643.773.586.313.613.913.843.443.431.552.132.432.881.43
0000.060.150.10.10.430.271.45000000000
0000000000000000000
00000000001.130000000.010.01
0000.060.150.10.10.430.271.451.130000000.010.01
1.642.331.813.13.633.743.874.016.585.065.043.843.443.431.552.132.432.891.44
0.771.871.545.054.367.4610.148.659.617.787.346.996.316.455.496.198.668.274.65
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Remedent provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Remedent's financial health and stability.

Assets

Remedent's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Remedent must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Remedent after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Remedent's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M USD)DEPRECIATION (M USD)DEFERRED TAXES (M USD)CHANGES IN WORKING CAPITAL (k USD)NON-CASH ITEM (M USD)PAID INTEREST (M USD)PAID TAXES (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (k USD)CAPITAL EXPENDITURES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (k USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k USD)INTEREST INCOME AND EXPENSES (M USD)NET DEBT CHANGE (k USD)NET CHANGE IN EQUITY (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M USD)TOTAL DIVIDENDS PAID (M USD)NET CHANGE IN CASH FLOW (k USD)FREE CASH FLOW (M USD)SHARE-BASED COMPENSATION (M USD)
200320042005200620072008200920102011201220132014201520162017201820192020
-100-3-1-3-2-30100000020
000000000000000000
000000000000000000
0-1,0000-1,00000-1,0001,0000000001,00001,0000
000100300-2-1-100-10-20
000000000000000000
000000000000000000
000-3,0000-2,000000000001,000000
0000000-10000000000
000000-1,000-1,0000-3,0001,0000000000
000000000-3,0001,0000000000
000000000000000000
000000001,00000000-1,000000
000305000200000000
00030520120100-1000
000000200001000000
000000000000000000
000001,0000-1,0001,000-1,00000000000
-0.61-0.570.5-3.4-1.05-2.66-1.51-0.85-0.67-0.53-1.13-0.140.06-0.321.630.020.570.1
000000000000000000

Remedent stock margins

The Remedent margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Remedent. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Remedent.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Remedent's sales revenue. A higher gross margin percentage indicates that the Remedent retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Remedent's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Remedent's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Remedent's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Remedent. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Remedent's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Remedent Margin History

Remedent Gross marginRemedent Profit marginRemedent EBIT marginRemedent Profit margin
202242.54 %16.42 %32.84 %
202150.52 %0 %0 %
202069.73 %-45.06 %-80.63 %
201969.66 %-44.73 %132.74 %
201866 %-11.14 %-2.02 %
201750.31 %-45.41 %35.84 %
201670.49 %0.26 %5.8 %
201564.59 %2.92 %2.91 %
201462.93 %-28.57 %20.08 %
201351.02 %-61.56 %-33.33 %
201276.99 %-5.16 %5.06 %
201168.6 %1.83 %-12.32 %
201047.64 %-35.76 %-28.48 %
200954.85 %-6.49 %-20.15 %
200846.93 %-41.04 %-41.71 %
200749.85 %-20.96 %-22.46 %
200648.44 %-42.22 %-52.64 %
200557.85 %12.59 %-1.41 %
200453.82 %13.74 %0.38 %
200346.19 %-31.98 %-51.27 %

Remedent Stock Sales Revenue, EBIT, Earnings per Share

The Remedent earnings per share therefore indicates how much revenue Remedent has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Remedent earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Remedent's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Remedent’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Remedent's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Remedent Revenue, EBIT and net profit per share

DateRemedent Sales per ShareRemedent EBIT per shareRemedent Earnings per Share
20220 USD0 USD0 USD
20210 USD0 USD0 USD
20200.05 USD-0.02 USD-0.04 USD
20190.08 USD-0.04 USD0.11 USD
20180.14 USD-0.02 USD-0 USD
20170.12 USD-0.05 USD0.04 USD
20160.14 USD0 USD0.01 USD
20150.18 USD0.01 USD0.01 USD
20140.13 USD-0.04 USD0.03 USD
20130.15 USD-0.09 USD-0.05 USD
20120.48 USD-0.02 USD0.02 USD
20110.63 USD0.01 USD-0.08 USD
20100.41 USD-0.15 USD-0.12 USD
20090.75 USD-0.05 USD-0.15 USD
20080.42 USD-0.17 USD-0.18 USD
20070.52 USD-0.11 USD-0.12 USD
20060.66 USD-0.28 USD-0.35 USD
20053.45 USD0.43 USD-0.05 USD
20042.56 USD0.35 USD0.01 USD
20031.08 USD-0.35 USD-0.55 USD

Remedent business model

Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent is one of the most popular companies on Eulerpool.com.

Remedent SWOT Analysis

Strengths

Remedent Inc possesses several strengths that contribute to its success in the market. Firstly, the company has a strong reputation for providing high-quality dental products and services. This reputation is built on decades of experience and a commitment to excellence.

Another strength of Remedent Inc is its innovative product portfolio. The company continually invests in research and development, leading to the creation of cutting-edge dental technologies and solutions. This allows Remedent Inc to stay ahead of its competitors and cater to the evolving needs of dental professionals.

Weaknesses

Despite its strengths, Remedent Inc also faces certain weaknesses that need to be addressed. One significant weakness is its limited market presence outside of its home country. Expanding into international markets would expose the company to a broader customer base and potential growth opportunities.

Additionally, Remedent Inc heavily relies on a few key suppliers, which can pose a risk to the company's supply chain. Diversifying the supplier base would reduce vulnerability and ensure uninterrupted product availability.

Opportunities

The dental industry presents several opportunities for Remedent Inc to capitalize on. One notable opportunity is the growing demand for cosmetic dental procedures. With its expertise in providing aesthetic dental solutions, Remedent Inc can further penetrate this market segment and cater to the increasing number of individuals seeking cosmetic enhancements.

Furthermore, the rising adoption of digital technologies in dentistry opens doors for Remedent Inc to develop and market advanced dental software and devices. Aligning with this trend can lead to new revenue streams and a competitive edge in the industry.

Threats

Remedent Inc faces various threats that could impact its business operations. One significant threat is the intense competition within the dental industry. The presence of established and emerging competitors requires Remedent Inc to continuously enhance its offerings and maintain its competitive position.

Moreover, economic downturns and changing reimbursement policies can affect consumer spending on dental procedures, potentially reducing demand for Remedent Inc's products and services. Monitoring economic and policy changes is crucial to mitigate such threats.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Remedent Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Remedent historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Remedent shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Remedent earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Remedent's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Remedent’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Remedent's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Remedent stock splits

In Remedent's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Remedent.

Remedent latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/2009-0.03 USD-0.04 USD (-30.72 %)2010 Q3
9/30/2009-0.03 USD-0.04 USD (-30.72 %)2010 Q2
6/30/2009-0.02 USD-0.03 USD (-47.06 %)2010 Q1
3/31/20090 USD-0.05 USD (0 %)2009 Q4
12/31/20080 USD-0.02 USD (0 %)2009 Q3
9/30/2008-0.02 USD-0.25 USD (-1,125.49 %)2009 Q2
6/30/20080 USD0.01 USD (0 %)2009 Q1
3/31/2008-0.05 USD-0.03 USD (41.18 %)2008 Q4
12/31/2007-0.04 USD-0.06 USD (-47.06 %)2008 Q3
9/30/2007-0.04 USD-0.05 USD (-22.55 %)2008 Q2
1
2

Remedent shareholders

%
Name
Stocks
Change
Date
23.16840 % De Vreese (Guy)4,633,68006/29/2020
12.66896 % Sternberg (Stuart L)2,533,79306/29/2020
0.47500 % Kolsteeg (Frederick)95,00006/29/2020
1

Remedent Executives and Management Board

Mr. Philippe Van Acker

(55)
Remedent Chief Financial Officer, Chief Accounting Officer, Director (since 2005)
Compensation 192,758 USD

Mr. Guy De Vreese

(65)
Remedent Chairman of the Board, Chief Executive Officer (since 2002)
Compensation 38,852 USD

Mr. Fred Kolsteeg

(77)
Remedent Independent Director
1

Remedent Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer-0,33-0,31-0,42
1

Most common questions regarding Remedent

What values and corporate philosophy does Remedent represent?

Remedent Inc represents a set of core values and corporate philosophy centered around excellence, innovation, and patient-centric care. The company's commitment to delivering high-quality dental solutions and improving smiles globally sets them apart. Remedent Inc believes in constantly pushing the boundaries of dental technology and offering state-of-the-art products and services to dental professionals and patients. With a focus on advanced aesthetic dentistry, they strive to enhance oral health outcomes and empower smiles. Remedent Inc's dedication to research, development, and collaboration ensures their position as a leading provider in the dental industry, promoting confidence and wellbeing for individuals worldwide.

In which countries and regions is Remedent primarily present?

Remedent Inc is primarily present in various countries and regions across the globe. The company has established its presence in North America, including the United States and Canada, catering to a wide range of customers. Additionally, Remedent Inc also operates in Europe, with a strong presence in countries like Belgium, Germany, Spain, and Italy. The company's international reach extends to Asia as well, with a presence in countries such as China, Japan, and South Korea. With its global presence, Remedent Inc aims to serve customers worldwide, offering innovative dental and cosmetic dentistry solutions.

What significant milestones has the company Remedent achieved?

Remedent Inc has achieved several significant milestones. The company successfully developed and launched its proprietary GlamSmile product, a revolutionary dental veneer system. With its powerful marketing and distribution network, Remedent expanded GlamSmile's availability to numerous countries, resulting in increasing global demand. The company also established strong partnerships with renowned dental professionals, enhancing its reputation and expertise in the field. Furthermore, Remedent Inc's commitment to research and innovation led to the launch of other world-class dental products, like its state-of-the-art CAD/CAM scanning and milling systems. These accomplishments have positioned Remedent Inc as a leading player in the dental industry, solidifying its presence in the market.

What is the history and background of the company Remedent?

Remedent Inc, a dental and oral care company, has a rich history and an impressive background. Founded in 1990, Remedent has been dedicated to delivering innovative dental solutions to patients worldwide. With a strong focus on creating beautiful and healthy smiles, the company has established itself as a global leader in dental aesthetics. Remedent offers a comprehensive range of products and services, including veneers, teeth whitening, and dental implants. With their commitment to research and development, Remedent continues to stay at the forefront of the dental industry, constantly adapting to evolving market needs. Over the years, the company's name has become synonymous with quality and success in the dental field.

Who are the main competitors of Remedent in the market?

The main competitors of Remedent Inc in the market include dental technology companies like Align Technology, Dentsply Sirona, Straumann Group, and Henry Schein.

In which industries is Remedent primarily active?

Remedent Inc is primarily active in the dental industry.

What is the business model of Remedent?

The business model of Remedent Inc. focuses on providing innovative dental solutions and products. Remedent Inc. is a leading global player in the dental industry, offering a range of advanced dental products, including the highly popular and successful GlamSmile veneer system. They aim to meet the increasing demand for aesthetic dental treatments by offering highly-effective, non-invasive solutions. With their cutting-edge technology and strategic partnerships, Remedent Inc. continues to revolutionize the dental industry and deliver exceptional results to patients worldwide.

What is the P/E ratio of Remedent 2024?

The P/E ratio cannot be calculated for Remedent at the moment.

What is the P/S ratio of Remedent 2024?

The P/S cannot be calculated for Remedent currently.

What is the Quality Investing of Remedent?

The Quality Investing for Remedent is 2/10.

What is the revenue of Remedent 2024?

The revenue cannot currently be calculated for Remedent.

How high is the profit of Remedent 2024?

The profit cannot currently be calculated for Remedent.

What is the business model of Remedent

Remedent Inc is a multinational company operating in the field of aesthetic dentistry. The company is based in Gent, Belgium, with offices in Asia, Europe, and North America. The company offers a wide range of products and services for dentists and patients. Lumineers and Veneers are the most common products offered. Lumineers are a type of ultra-thin veneers made of porcelain, used to improve the appearance of teeth. Veneers are thin shells made of porcelain or ceramic that are applied to the teeth to improve their shape, color, and size. Remedent Inc also offers aligner systems. Aligner systems allow for gentle movement of teeth to correct misalignments or perform orthodontic treatment. The company offers various aligner systems that provide improved aesthetics and comfort. Another important division of Remedent Inc is the manufacturing of digital solutions for dentistry. Services range from patient treatment to implant planning and digital fabrication of crowns and bridges. This technology provides dentists and orthodontists with a fast and accurate way to treat patients. The company works closely with dentists and partner laboratories to facilitate treatment and achieve the best outcome for patients. This includes not only the functionality of the tooth but also the aesthetics and confidence of the patients. Remedent Inc follows an innovative business model focused on continuous improvement and innovation. The company heavily invests in research and development to offer the latest technologies and techniques in dentistry. This allows the company to continually expand its offering of products and services and differentiate itself from competitors. Another important aspect of Remedent Inc's business model is its close collaboration with various distribution partners worldwide. This collaboration allows the company to adapt its products and services to different markets and identify global trends and needs. This is advantageous for the company as it can achieve higher market penetration and revenues. The various divisions of Remedent Inc provide a wide range of products and services for dentists and patients worldwide. The company's extensive research and development and its innovative technological platform drive its continuous growth. Remedent Inc's business model is focused on providing improved dentistry that is both functional and aesthetically appealing to patients and dentists. Overall, Remedent Inc is one of the leading companies in this field and is expected to continue playing a significant role in the future.

What is the Remedent dividend?

Remedent pays a dividend of 0 USD distributed over payouts per year.

How often does Remedent pay dividends?

The dividend cannot currently be calculated for Remedent or the company does not pay out a dividend.

What is the Remedent ISIN?

The ISIN of Remedent is US75954T1043.

What is the Remedent WKN?

The WKN of Remedent is A0ERVL.

What is the Remedent ticker?

The ticker of Remedent is REMI.

How much dividend does Remedent pay?

Over the past 12 months, Remedent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Remedent is expected to pay a dividend of 0 USD.

What is the dividend yield of Remedent?

The current dividend yield of Remedent is .

When does Remedent pay dividends?

Remedent pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Remedent?

Remedent paid dividends every year for the past 0 years.

What is the dividend of Remedent?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Remedent located?

Remedent is assigned to the 'Health' sector.

Wann musste ich die Aktien von Remedent kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Remedent from 12/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.

When did Remedent pay the last dividend?

The last dividend was paid out on 12/4/2024.

What was the dividend of Remedent in the year 2023?

In the year 2023, Remedent distributed 0 USD as dividends.

In which currency does Remedent pay out the dividend?

The dividends of Remedent are distributed in USD.

All fundamentals about Remedent

Our stock analysis for Remedent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Remedent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.